论文部分内容阅读
我院于1997年8月起应用国产首家重组人粒细胞集落刺激因子-特尔立(厦门特宝生物工程有限公司研制的ｒｈｕＧＭ-ＣＳＦ,冻干粉针)治疗非何杰金淋巴瘤化疗后粒细胞减少,取得了良好的疗效,现报道如下。1 资料和方法1.1 用药组 非何杰金淋巴瘤(ＮＨＬ)患者10例,均为我院的住院病
In August 1997, our hospital applied the first domestic recombinant human granulocyte colony stimulating factor-Telli (rhuGM-CSF, developed by Xiamen Tebao Bioengineering Co., Ltd., freeze-dried powder injection) to treat non-Hodgkin’s lymphoma. The reduction of granulocytes and good results are reported below. 1 Materials and Methods 1.1 Medication group 10 patients with non-Hodgkin’s lymphoma (NHL) were hospitalized in our hospital